R&D Partner Content 9th Microbiome Movement Summit Europe Translating Microbiome R&D into Improved Healthcare Outcomes & Commercial Potential
Partner Content Partner Content Exclusive Interview with Martin Everett, CSO, Antabio, speak... Exclusive Interview with Martin Everett
Partner Content Partner Content SMi’s Pharma Microbiology in Boston 2-day event what to expe... SMi’s Pharmaceutical Microbiology in Boston
Partner Content Partner Content Invite from Lynne Ensor chair for Pharma Microbiology East C... Invite from Lynne Ensor chair for Pharma Microbiology
Partner Content Partner Content Registration Opens for SMi’s 3rd Annual Pharmaceutical Micro... Registration Opens SMi’s Pharma Microbiology Boston
Partner Content Partner Content Top decision makers to present at SMi’s 9th Annual Pharma Mi... Top decision makers to present at Pharma Microbiology
Digital On AI and computational support of biochemistry, with Alan R... Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.
